<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for SciClone Pharmaceuticals, Inc. - Google Finance</title>
<description>News for SciClone Pharmaceuticals, Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:SCLN&amp;amp;client=news-rss&amp;amp;ei=8rKbUeCeFeiy0AGbIQ</link>
<image>
<title>News for SciClone Pharmaceuticals, Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:SCLN&amp;amp;client=news-rss&amp;amp;ei=8rKbUeCeFeiy0AGbIQ</link>
</image>
<item>
<title>SCICLONE PHARMACEUTICALS, INC. : SciClone and Zensun Enter Into a ...</title>
<link>http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-and-Zensun-Enter-Into-a-Licensing-Agreement-for-Novel-Chro-16868164/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-and-Zensun-Enter-Into-a-Licensing-Agreement-for-Novel-Chro-16868164/</guid>
<pubDate>Thu, 16 May 2013 20:16:26 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-and-Zensun-Enter-Into-a-Licensing-Agreement-for-Novel-Chro-16868164/&quot; style=&quot;font-size:1.2em&quot;&gt;SCICLONE PHARMACEUTICALS, INC. : SciClone and Zensun Enter Into a ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;FOSTER CITY, CA -- (Marketwired) -- 05/16/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement with Zensun (Shanghai) Science &amp;amp; Technology Co.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>SCICLONE PHARMACEUTICALS, INC. : SciClone Reports Anticipated Financial ...</title>
<link>http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-Reports-Anticipated-Financial-Results-for-the-First-Quarte-16868165/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-Reports-Anticipated-Financial-Results-for-the-First-Quarte-16868165/</guid>
<pubDate>Thu, 16 May 2013 20:16:27 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/SCICLONE-PHARMACEUTICALS-10772/news/SciClone-Pharmaceuticals-Inc-SciClone-Reports-Anticipated-Financial-Results-for-the-First-Quarte-16868165/&quot; style=&quot;font-size:1.2em&quot;&gt;SCICLONE PHARMACEUTICALS, INC. : SciClone Reports Anticipated Financial ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;FOSTER CITY, CA -- (Marketwired) -- 05/16/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported its expectations regarding financial results for the quarter ended March 31, 2013.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Here is What Hedge Funds Think About SciClone Pharmaceuticals, Inc. (SCLN)</title>
<link>http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-sciclone-pharmaceuticals-inc-scln-125027/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-sciclone-pharmaceuticals-inc-scln-125027/</guid>
<pubDate>Tue, 23 Apr 2013 14:50:49 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-sciclone-pharmaceuticals-inc-scln-125027/&quot; style=&quot;font-size:1.2em&quot;&gt;Here is What Hedge Funds Think About SciClone Pharmaceuticals, Inc. (SCLN)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) investors should be aware of an increase in activity from the world&amp;#39;s largest hedge funds lately.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Sucampo Pharmaceuticals, Inc. (SCMP): Why You Should Consider Buying In ...</title>
<link>http://www.insidermonkey.com/blog/sucampo-pharmaceuticals-inc-scmp-why-you-should-consider-buying-in-right-now-127148/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778131198186</guid>
<pubDate>Thu, 25 Apr 2013 15:25:17 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/sucampo-pharmaceuticals-inc-scmp-why-you-should-consider-buying-in-right-now-127148/&quot; style=&quot;font-size:1.2em&quot;&gt;Sucampo Pharmaceuticals, Inc. (SCMP): Why You Should Consider Buying In ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Let&amp;#39;s also examine hedge fund and insider activity in other stocks similar to Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP).&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart ...</title>
<link>http://seekingalpha.com/article/1445331-china-biotech-in-review-sciclone-pharma-in-licenses-china-rights-to-heart-failure-drug</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982066198735</guid>
<pubDate>Sun, 19 May 2013 13:16:25 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1445331-china-biotech-in-review-sciclone-pharma-in-licenses-china-rights-to-heart-failure-drug&quot; style=&quot;font-size:1.2em&quot;&gt;China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 19, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;SciClone Pharma (NSDQ: SCLN) in-licensed China rights to a heart failure drug from Zensun (Shanghai) Science &amp;amp; Technology Co.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>SciClone Reaches Neucardin Deal; Projects Weaker 1st Quarter</title>
<link>http://online.wsj.com/article/BT-CO-20130516-713693.html?mod=googlenews_wsj</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://online.wsj.com/article/BT-CO-20130516-713693.html?mod=googlenews_wsj</guid>
<pubDate>Thu, 16 May 2013 21:11:32 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130516-713693.html?mod=googlenews_wsj&quot; style=&quot;font-size:1.2em&quot;&gt;SciClone Reaches Neucardin Deal; Projects Weaker 1st Quarter&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;SciClone Pharmaceuticals Inc. (SCLN) said it entered into a drug agreement with Zensun (Shanghai) Science &amp;amp; Technology Co.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH - NASDAQ.com</title>
<link>http://www.nasdaq.com/article/us-hot-stock-futures-hot-stocks-to-watch-20130517-00177</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982064195819</guid>
<pubDate>Fri, 17 May 2013 12:35:18 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/us-hot-stock-futures-hot-stocks-to-watch-20130517-00177&quot; style=&quot;font-size:1.2em&quot;&gt;U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH - NASDAQ.com&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NASDAQ&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;(WWAV). Northrop Grumman Corp. ( NOC ) has approved an additional $4 billion in share repurchases as the defense firm continues its efforts to boost shareholder returns.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Sciclone Pharmaceuticals Inc Announces Update On Filing Of 2012 Annual Report On Form 10-K</title>
<link>http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2713004</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2713004</guid>
<pubDate>Thu, 14 Mar 2013 20:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2713004&quot; style=&quot;font-size:1.2em&quot;&gt;Sciclone Pharmaceuticals Inc Announces Update On Filing Of 2012 Annual Report On Form 10-K&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Mar 14, 2013 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Sciclone Pharmaceuticals Inc Issues FY 2013 Guidance; Revenue Guidance Below Analysts&amp;#39; Estimates</title>
<link>http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2676730</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2676730</guid>
<pubDate>Mon, 07 Jan 2013 11:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2676730&quot; style=&quot;font-size:1.2em&quot;&gt;Sciclone Pharmaceuticals Inc Issues FY 2013 Guidance; Revenue Guidance Below Analysts&amp;#39; Estimates&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jan 7, 2013 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Sciclone Pharmaceuticals Inc Lowers FY 2012 Guidance</title>
<link>http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2640597</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:2640597</guid>
<pubDate>Fri, 09 Nov 2012 11:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/SCLN.O/key-developments/article/2640597&quot; style=&quot;font-size:1.2em&quot;&gt;Sciclone Pharmaceuticals Inc Lowers FY 2012 Guidance&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 9, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
